(Q48466159)

11 February 2018

title

Effects of NMDA antagonism on striatal dopamine release in healthy subjects: application of a novel PET approach. (English)

1 reference

11 February 2018

0 references

1 reference

Breier A

1

1 reference

11 February 2018

Adler CM

2

1 reference

11 February 2018

Weisenfeld N

3

1 reference

11 February 2018

Su TP

4

1 reference

11 February 2018

Elman I

5

1 reference

11 February 2018

Picken L

6

1 reference

11 February 2018

Malhotra AK

7

1 reference

11 February 2018

Pickar D

8

1 reference

11 February 2018

publication date

1 June 1998

1 reference

11 February 2018

published in

Synapse

1 reference

11 February 2018

volume

29

1 reference

11 February 2018

issue

2

1 reference

11 February 2018

page(s)

142-147

1 reference

11 February 2018

Observations on the psychotomimetic effects of Sernyl.

cites work

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199806%2929%3A2%3C142%3A%3AAID-SYN5%3E3.0.CO%3B2-7

Observations on the action of Sernyl-a new psychotropic drug.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199806%2929%3A2%3C142%3A%3AAID-SYN5%3E3.0.CO%3B2-7

Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199806%2929%3A2%3C142%3A%3AAID-SYN5%3E3.0.CO%3B2-7

Schizophrenia: a subcortical neurotransmitter imbalance syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199806%2929%3A2%3C142%3A%3AAID-SYN5%3E3.0.CO%3B2-7

Comparison of bolus and infusion methods for receptor quantitation: application to [18F]cyclofoxy and positron emission tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199806%2929%3A2%3C142%3A%3AAID-SYN5%3E3.0.CO%3B2-7

In vivo presynaptic control of dopamine release in the cat caudate nucleus--II. Facilitatory or inhibitory influence of L-glutamate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199806%2929%3A2%3C142%3A%3AAID-SYN5%3E3.0.CO%3B2-7

Inhibition of mammalian brain acetylcholinesterase by ketamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199806%2929%3A2%3C142%3A%3AAID-SYN5%3E3.0.CO%3B2-7

21 January 2018

Dissociative Anesthesia

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199806%2929%3A2%3C142%3A%3AAID-SYN5%3E3.0.CO%3B2-7

Actions of clozapine and haloperidol on the extracellular levels of excitatory amino acids in the prefrontal cortex and striatum of conscious rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199806%2929%3A2%3C142%3A%3AAID-SYN5%3E3.0.CO%3B2-7

Effects of central cholinergic blockade on striatal dopamine release measured with positron emission tomography in normal human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199806%2929%3A2%3C142%3A%3AAID-SYN5%3E3.0.CO%3B2-7

Striatal binding of the PET ligand 11C-raclopride is altered by drugs that modify synaptic dopamine levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199806%2929%3A2%3C142%3A%3AAID-SYN5%3E3.0.CO%3B2-7

Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199806%2929%3A2%3C142%3A%3AAID-SYN5%3E3.0.CO%3B2-7

Altered metabolic activity in the cerebral cortex of rats exposed to ketamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199806%2929%3A2%3C142%3A%3AAID-SYN5%3E3.0.CO%3B2-7

Amphetamine-stimulated dopamine release competes in vivo for [123I]IBZM binding to the D2 receptor in nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199806%2929%3A2%3C142%3A%3AAID-SYN5%3E3.0.CO%3B2-7

NMDA-associated glycine binding site increases in schizophrenic brains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199806%2929%3A2%3C142%3A%3AAID-SYN5%3E3.0.CO%3B2-7

Increases in strychnine-insensitive glycine binding sites in cerebral cortex of chronic schizophrenics: evidence for glutamate hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199806%2929%3A2%3C142%3A%3AAID-SYN5%3E3.0.CO%3B2-7

Recent advances in the phencyclidine model of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199806%2929%3A2%3C142%3A%3AAID-SYN5%3E3.0.CO%3B2-7

Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199806%2929%3A2%3C142%3A%3AAID-SYN5%3E3.0.CO%3B2-7

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199806%2929%3A2%3C142%3A%3AAID-SYN5%3E3.0.CO%3B2-7

Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199806%2929%3A2%3C142%3A%3AAID-SYN5%3E3.0.CO%3B2-7

Effects of blood flow on [11C]raclopride binding in the brain: model simulations and kinetic analysis of PET data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199806%2929%3A2%3C142%3A%3AAID-SYN5%3E3.0.CO%3B2-7

NMDA receptor function and human cognition: the effects of ketamine in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199806%2929%3A2%3C142%3A%3AAID-SYN5%3E3.0.CO%3B2-7

Effect of L-glutamate on the release of striatal dopamine: in vivo dialysis and electrochemical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199806%2929%3A2%3C142%3A%3AAID-SYN5%3E3.0.CO%3B2-7

Glutamate receptor dysfunction and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199806%2929%3A2%3C142%3A%3AAID-SYN5%3E3.0.CO%3B2-7

Low dose intravenous infusion technique with ketamine. Amnesic, analgesic and sedative effects in human volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199806%2929%3A2%3C142%3A%3AAID-SYN5%3E3.0.CO%3B2-7

Evidence of glutamatergic deficiency in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199806%2929%3A2%3C142%3A%3AAID-SYN5%3E3.0.CO%3B2-7

The interaction of ketamine with the opiate receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199806%2929%3A2%3C142%3A%3AAID-SYN5%3E3.0.CO%3B2-7

Properties of the optical isomers and metabolites of ketamine on the high affinity transport and catabolism of monoamines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199806%2929%3A2%3C142%3A%3AAID-SYN5%3E3.0.CO%3B2-7

PCP-induced alterations in cerebral glucose utilization in rat brain: blockade by metaphit, a PCP-receptor-acylating agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199806%2929%3A2%3C142%3A%3AAID-SYN5%3E3.0.CO%3B2-7

An N-methylaspartate receptor-mediated synapse in rat cerebral cortex: a site of action of ketamine?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199806%2929%3A2%3C142%3A%3AAID-SYN5%3E3.0.CO%3B2-7

Abnormal excitatory neurotransmitter metabolism in schizophrenic brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-2396%28199806%2929%3A2%3C142%3A%3AAID-SYN5%3E3.0.CO%3B2-7

10.1002/(SICI)1098-2396(199806)29:2<142::AID-SYN5>3.0.CO;2-7

21 January 2018

Identifiers

DOI

1 reference

11 February 2018

1 reference

11 February 2018